Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

about

Q57040007

sameAs

Q58611561-B251AC36-5FBC-4F2A-800C-5DDD40E8FD33 Q59054693-A1A8F321-EF10-4D9A-BE95-08743A242A23

P642

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

Item

http://www.wikidata.org/entity/Q57039969

description

article publié dans la revue scientifique Nature

@fr

scientific article published in Nature

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в Nature в жовтні 2018

@uk

name

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

@en

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

@nl

type

Item

label

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

@en

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

@nl

prefLabel

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

@en

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

@nl

P1476

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

@en

P2093

Abishek Chandrashekar

http://www.w3.org/2001/XMLSchema#string

Anthony M Cadena

http://www.w3.org/2001/XMLSchema#string

Dan H Barouch

http://www.w3.org/2001/XMLSchema#string

David Jetton

http://www.w3.org/2001/XMLSchema#string

Edward T Moseley

http://www.w3.org/2001/XMLSchema#string

Elena Bekerman

http://www.w3.org/2001/XMLSchema#string

Erica N Borducchi

http://www.w3.org/2001/XMLSchema#string

Galit Alter

http://www.w3.org/2001/XMLSchema#string

Jinyan Liu

http://www.w3.org/2001/XMLSchema#string

Joseph Hesselgesser

http://www.w3.org/2001/XMLSchema#string

P2507

Publisher Correction: Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

P2860

Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

Broad neutralization coverage of HIV by multiple highly potent antibodies

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.

Early antibody therapy can induce long-lasting immunity to SHIV

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

Immunologic strategies for HIV-1 remission and eradication.

P2888

s41586-018-0600-6

P304

360-364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41586-018-0600-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

7731

http://www.w3.org/2001/XMLSchema#string

P478

563

http://www.w3.org/2001/XMLSchema#string

P50

Peter Abbink

Mark G Lewis

P577

2018-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1107363297

http://www.w3.org/2001/XMLSchema#string

P698

30283138

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

6237629

http://www.w3.org/2001/XMLSchema#string

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

about

sameAs

P642

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

description

name

type

label

prefLabel

P1433

P1476

P2093

P2507

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2507

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932